<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Syndromic and <z:hpo ids='HP_0003745'>sporadic</z:hpo> fundic gland <z:mpath ids='MPATH_491'>polyps</z:mpath> are morphologically indistinguishable but may arise via different pathogenetic mechanisms involving mutations of the <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC) and its downstream target beta-catenin genes </plain></SENT>
<SENT sid="1" pm="."><plain>Although a higher frequency of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> has been reported in syndromic forms, the risk of developing invasive <z:mp ids='MP_0002038'>carcinoma</z:mp> is exceedingly low </plain></SENT>
<SENT sid="2" pm="."><plain>The current study was designed to investigate whether syndromic and <z:hpo ids='HP_0003745'>sporadic</z:hpo> fundic gland <z:mpath ids='MPATH_491'>polyps</z:mpath> differ in protein expression of a number of genes that are thought to be important in the control of <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>A total of 262 fundic gland <z:mpath ids='MPATH_491'>polyps</z:mpath>, including 155 syndromic <z:mpath ids='MPATH_491'>polyps</z:mpath> obtained from 35 patients with <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">familial adenomatous polyposis</z:e> or <z:e sem="disease" ids="C0017097" disease_type="Neoplastic Process" abbrv="">Gardner's syndrome</z:e> and 107 <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:mpath ids='MPATH_491'>polyps</z:mpath> randomly selected from 45 patients with <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> or <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, were included in this study </plain></SENT>
<SENT sid="4" pm="."><plain>Immunohistochemical evaluation showed that loss of immunoreactivity to the antibody against the carboxyl terminus of the APC protein, presumably resulting from APC gene mutations, was more frequent in syndromic than in <z:hpo ids='HP_0003745'>sporadic</z:hpo> cases (40% versus 6.7%, P&lt;0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>However, immunostaining failed to show aberrant nuclear localization of beta-catenin, a protein regulated by APC, in any of the <z:mpath ids='MPATH_491'>polyps</z:mpath>, irrespective of syndromic or <z:hpo ids='HP_0003745'>sporadic</z:hpo> types </plain></SENT>
<SENT sid="6" pm="."><plain>Instead, positive membranous staining for beta-catenin was observed in <z:hpo ids='HP_0000001'>all</z:hpo> the cases </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, the expression characteristics of 2 other proteins, c-Myc and cyclin D1, whose genes have been reported to be transcriptionally regulated by the APC/beta-catenin pathway, were similar in these two types of <z:mpath ids='MPATH_491'>polyps</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, <z:hpo ids='HP_0000001'>all</z:hpo> cases, including those harboring <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, showed negative nuclear staining for p53 and positive nuclear staining for <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo> (RB) </plain></SENT>
<SENT sid="9" pm="."><plain>Taken together, these data show a lack of dysregulation in the APC/beta-catenin signaling pathway and in the expression of p53 and RB in fundic gland <z:mpath ids='MPATH_491'>polyps</z:mpath> despite a high frequency of <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> of the APC and beta-catenin genes reported in these <z:mpath ids='MPATH_491'>polyps</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>These findings may explain at least in part why fundic gland <z:mpath ids='MPATH_491'>polyps</z:mpath> show a negligible malignant potential even in the presence of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
</text></document>